Current Concepts In Treating Diabetic Foot Osteomyelitis

Start Page: 20
William B. Hoffman, BS, Khurram H. Khan, DPM, FAPWCA, and Mark Kosinski, DPM, FIDSA

1. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004;39(7):885-910.
2. Game FL, Jeffcoate WJ. Primarily non-surgical management of osteomyelitis of the foot in diabetes. Diabetologia 2008;51(6):962-7.
3. Embil JM, Rose G, Trepman E, et al. Oral antimicrobial therapy for diabetic foot osteomyelitis. Foot Ankle Int 2006; 27(10):771-9.
4. Senneville E, Lombart A, Beltrand E, et al. Outcome of diabetic foot osteomyelitis treated nonsurgically: a retrospective cohort study. Diabetes Care 2008;31(4):637-42.
5. Neut D, van der Mei HC, Bulstra SK, et al. The role of small-colony variants in failure to diagnose and treat biofilm infections in orthopedics. Acta Orthop 2007;78(3):299-308.
6. Henke PK, Blackburn SA, Wainess RW, et al. Osteomyelitis of the foot and toe in adults is a surgical disease: conservative management worsens lower extremity salvage. Ann Surg 2005;241(6):885-92.
7. Bamberger DM, Daus GP, Gerding, DN. Osteomyelitis of diabetic patients, long term results, prognostic factors, and the role of antimicrobial and surgical therapy. Am J Med 1987; 83(4):653-660.
8. Haas DW, McAndrew MP. Bacterial osteomyelitis in adult: evolving considerations in diagnosis and treatment. Am J Med 1996; 101(5):550-561.
9. Lew DP, Waldvogel FA. Osteomyelitis. New Engl J Med. 1997; 336(14):999-1007.
10. Lipsky BA. Osteomyelitis of the foot in diabetic patients. Clin Infect Dis 1997; 25(6):1318-1326.
11. Jeffcoate WJ, Lipsky BA. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis. Aug 1 2004;39 Suppl 2:S115-122.
12. Senneville E, Yazdanpanah Y, Cazaubiel M, et al. Rifampin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis. J Antimicrob Chemother 2001; 48(6):927-30
13. Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O’Toole GA. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 2003; 426(6964):306-10.
14. Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis 2001; 33: S94-106.
15. Jefferson KK, Goldmann DA, Pier GB. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob Agents Chemother 2005; 49(6):2467-73.
16. Cochran WL, Suh SJ, McFeters GA, Stewart PS. Role of RpoS and AlgT in Pseudomonas aeruginosa biofilm resistance to hydrogen peroxide and monochloramine. J Appl Microbiol 2000; 88(3):546-53.
17. Cogan NG. Effects of persister formation on bacterial response to dosing. J Theor Biol 2006; 238(3):694-703.
18. Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry (Mosc) 2005; 70(2):267-74.
19. Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 2002; 292(2):107-13.
20. Bergoge-Berezin E. Resistance and new antibiotic strategies. The problem with staphylococcus. Presse Med 2000; 29(37): 2018-21.
21. Proctor RA, Van Langevelde P, Kristjansson M, Maslow JN, Arbeit RD. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin Infect Dis 1995; 20(1):95-102.
22. Looney WJ. Small-colony variants of Staphylococcus aureus. Br J Biomed Sci 2000; 57(4):317-22.

image description image description

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Enter the characters shown in the image.